(Q56752696)

1

0 references

R Suzuki

2

0 references

Y Atsuta

3

0 references

M Iida

4

0 references

D-P Lu

5

0 references

W Tong

6

0 references

A Ghavamzadeh

7

0 references

K Alimoghaddam

8

0 references

A K W Lie

9

0 references

R Liang

10

0 references

L L Chan

11

0 references

L Haipeng

12

0 references

P-L Tan

13

0 references

W Y K Hwang

14

0 references

T-J Chiou

15

0 references

P-M Chen

16

0 references

T Van Binh

17

0 references

N N Minh

18

0 references

C-K Min

19

0 references

T J Hwang

20

0 references

Y Kodera

Bone Marrow Transplantation

21

0 references

language of work or name

English

0 references

publication date

December 2010

0 references

published in

0 references

volume

45

0 references

issue

12

0 references

page(s)

1682-91

0 references

exact match

https://scigraph.springernature.com/pub.10.1038/bmt.2010.34

0 references

cites work

Hematopoietic stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.34

Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.34

Current status of hematopoietic cell transplantation for adult patients with hematologic diseases and solid tumors in Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.34

Blood and marrow transplantation in the People's Republic of China

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.34

Stem cell transplantation in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.34

The hematopoietic stem cell transplantation in Indonesia: an unsolved dilemma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.34

The activity of hematopoietic stem cell transplantation in Korea

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.34

The stem cell transplant program in Pakistan--the first decade

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.34

Stem cell transplantation programme at Singapore General Hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.34

Current status of hematopoietic stem cell transplantation in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.34

Hematopoietic stem cell transplantation in Thailand.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.34

Current status of hematopoietic stem cell transplantations in Vietnam

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.34

Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.34

Economics, health care systems and utilization of haematopoietic stem cell transplants in Europe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.34

Results of the EBMT activity survey 2005 on haematopoietic stem cell transplantation: focus on increasing use of unrelated donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.34

Cost-effectiveness of imatinib versus interferon-alpha plus low-dose cytarabine for patients with newly diagnosed chronic-phase chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.34

Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Philadelphia Bone Marrow Transplant Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.34

High-dose versus standard chemotherapy in metastatic breast cancer: comparison of Cancer and Leukemia Group B trials with data from the Autologous Blood and Marrow Transplant Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.34

EBMT activity survey 2004 and changes in disease indication over the past 15 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.34

Haematopoietic stem cell transplantation (HSCT) in Europe 2002. Changes in indication and impact of team density. A report of the EBMT activity survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.34

Current trends in hematopoietic stem cell transplantation in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.34

7 January 2021

Bone marrow and stem cell transplantation: Malaysian experience

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.34

7 January 2021

The status of blood and marrow transplantation in Philippines

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.34

7 January 2021

Allogeneic peripheral blood progenitor cell transplantation: the Taiwan experience

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.34

7 January 2021

Marrow donor registry and bone marrow transplantation from unrelated donors in Taiwan: initial experience of the Tzu Chi Taiwan Marrow Donor Registry (TCTMDR)

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.34

7 January 2021

The EBMT activity survey 2006 on hematopoietic stem cell transplantation: focus on the use of cord blood products

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.34

7 January 2021

Hematopoietic stem cell transplants for chronic myeloid leukemia in Europe--impact of cost considerations

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.34

7 January 2021

High-dose chemotherapy for breast cancer: the French PEGASE experience

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.34

7 January 2021

High-dose chemotherapy and autologous hematopoietic stem cell transplantation for metastatic breast cancer: a therapy whose time has passed

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.34

7 January 2021

Change in stem cell source for hematopoietic stem cell transplantation (HSCT) in Europe: a report of the EBMT activity survey 2003

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.34

7 January 2021